On Monday, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) was -5.33% drop from the session before settling in for the closing price of $2.25. A 52-week range for MRVI has been $1.66 – $10.03.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.61% over the past five years. When this article was written, the company’s average yearly earnings per share was at -180.40%. With a float of $107.06 million, this company’s outstanding shares have now reached $143.96 million.
Let’s look at the performance matrix of the company that is accounted for 570 employees. In terms of profitability, gross margin is 37.29%, operating margin of -109.95%, and the pretax margin is -120.64%.
Maravai LifeSciences Holdings Inc (MRVI) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Maravai LifeSciences Holdings Inc stocks. The insider ownership of Maravai LifeSciences Holdings Inc is 18.99%, while institutional ownership is 77.13%. The most recent insider transaction that took place on Jan 31 ’25, was worth 125,750. In this transaction General Counsel of this company sold 25,000 shares at a rate of $5.03, taking the stock ownership to the 167,618 shares. Before that another transaction happened on Jan 31 ’25, when Company’s Officer proposed sale 25,000 for $5.03, making the entire transaction worth $125,750.
Maravai LifeSciences Holdings Inc (MRVI) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -180.40% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.33% during the next five years compared to -64.27% drop over the previous five years of trading.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Trading Performance Indicators
You can see what Maravai LifeSciences Holdings Inc (MRVI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Maravai LifeSciences Holdings Inc (MRVI)
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) saw its 5-day average volume 1.57 million, a negative change from its year-to-date volume of 2.79 million. As of the previous 9 days, the stock’s Stochastic %D was 50.82%. Additionally, its Average True Range was 0.16.
During the past 100 days, Maravai LifeSciences Holdings Inc’s (MRVI) raw stochastic average was set at 10.23%, which indicates a significant decrease from 38.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.18% in the past 14 days, which was lower than the 87.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.08, while its 200-day Moving Average is $5.13. Nevertheless, the first resistance level for the watch stands at $2.24 in the near term. At $2.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.40. If the price goes on to break the first support level at $2.07, it is likely to go to the next support level at $2.02. The third support level lies at $1.91 if the price breaches the second support level.
Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) Key Stats
There are 254,660K outstanding shares of the company, which has a market capitalization of 542.42 million. As of now, sales total 259,190 K while income totals -144,850 K. Its latest quarter income was 46,850 K while its last quarter net income were -29,950 K.
